Savaria Corp (SIS.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Savaria Corp (SIS.TO)

28.24

-0.50 (1.74%)

as of Aug 28, 2026, 8:00:00 pm Market Open.

307 watching

Investor Insights

Aug 30, 2026, 12:00 am

This summary was created by AI, based on 5 opinions in the last 12 months.

Savaria Corp (SIS-T) has garnered positive reviews from various experts, highlighting its resilience and potential for growth despite challenges such as tariffs. Analysts note that the company has shifted its focus towards Europe and is benefitting from trends in the accessibility industry, aimed at serving an aging population that prefers aging in place. The stock experienced fluctuations but has shown a strong recovery, with products that are compliant with CUSMA and many being FDA-regulated, making them less susceptible to tariffs. With an emphasis on cost-cutting and innovative product development, Savaria appears well-positioned for continued growth. Currently, it offers a yield of 2.69% and has an analysts’ price target of $24.44, suggesting a favorable outlook for potential investors.

Consensus

Positive

Valuation

Fair Value

Similar

SHY, SCHO

BUY

Stair lifts and mobility aids. Huge demographic tail winds. A very well managed company. A good distribution network in Canada. He really likes the company. Great growth ahead and a great segment to be in.

COMMENT

He doesn’t cover this one formally, but did put it in one of his portfolios because he likes it. Thinks there is lots of opportunity here. Management knows what they are doing. The growth rate is there. Valuation is acceptable. He likes the demographic play they have on the healthcare market. Management owns a big chunk.

TOP PICK

Health care sector. Most of the rest in the sector is too expensive. They make accessibility equipment for the mobility challenged and do the conversion of minivans. It is a unique company. The family owns 50% of the stock.

SELL

Two businesses. One is for in-home lift systems. The second is elevators in your home for cars. The demographics for the medical lifts are obviously quite positive, but the others are negative. He sold because it was getting pricy.

TRADE

Made $0.16 a share last year and $0.13 last nine months. Agrees that demographics are important and this industry is growing. Cdn$ is negative for them. Have a strategy to buy distributors in North America.

BUY

A microcap. Trading at about 15 X EPS forward multiple. Nice growth through the years but are exposed to the US$. Reducing costs and making an acquisition. Margins should go up.

Showing 121 to 126 of 126 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Jim Lebenthal

Cerity Partners

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Brianne Gardner

Raymond James

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Savaria Corp (SIS.TO)